Vitamin D and psoriasis: low levels are real, and the supplement trials disagree with each other

Two questions wearing one name

Vitamin D comes up in nearly every conversation about psoriasis and diet, and it comes up with an air of settledness that the evidence does not have. The reason is that two separate questions share the name. Do people with psoriasis have lower vitamin D than other people? And does giving them vitamin D make the psoriasis better? The first has a fairly clear answer. The second does not, and most of what you read treats the first as if it settled the second.

It is a natural slide. Low vitamin D is described in the research as a risk factor for psoriasis ^[6], vitamin D sounds like a nutrient rather than a drug, and so a tablet feels sensible. A feeling is not evidence that the tablet works, and the trials that could provide that evidence have been run, pooled, and pooled again, with results that ought to make anyone cautious.

The association: lower levels, measured many times

Start with the part that holds up. A 2023 systematic review pooled twenty-three studies that had measured blood vitamin D in people with psoriasis and in controls, covering 1876 patients and 7532 controls. People with psoriasis had significantly lower levels, 21.0 against 27.3 on the usual measure, and lower parathyroid hormone as well ^[6]. That is a pooled difference across twenty-three studies, and it is why the review describes hypovitaminosis D as a risk factor.

What an association of that kind cannot do is tell you which way the arrow points, or whether it points at all. A difference in blood levels between two groups can come from the disease, from what the disease does to how people live, or from the conditions that travel with it; the review that measured it says only that the levels are lower, not why ^[6]. The measurement is real. The mechanism is not established by it.

Sources for this section: [6] Psoriasis and Vitamin D: A Systematic Review and Meta-Analysis

The trials: four pooled analyses, three of them saying no

The direct test is a randomised trial: give people with psoriasis oral vitamin D or a placebo and measure the plaques. Those trials exist, they are small, and they have been pooled by four different groups with four slightly different answers.

The 2021 meta-analysis found a reduction in the severity index after six months that was statistically significant on one method and became non-significant after a standard adjustment for the small number of trials; its authors concluded that a favourable effect could not be verified ^[3]. The 2023 review that established the association also pooled four randomised trials, 173 people on vitamin D against 160 on placebo, and found no significant difference in severity at three, six or twelve months ^[6]. A second 2023 meta-analysis of 333 patients from four studies found no significant effect on severity, quality of life or inflammatory markers, and described the efficacy of supplementation as unremarkable ^[7].

Then there is the outlier. A 2025 network meta-analysis of dietary supplements in plaque psoriasis, pooling twenty-one trials across several supplements, reported that vitamin D significantly reduced the severity index, with a mean difference of -3.29 and a confidence interval running from -6.38 to -0.20, while rating the overall certainty as low to moderate and calling for larger confirmatory trials with standardised dosing ^[8]. A confidence interval whose upper bound nearly touches zero, from a pooled analysis its own authors describe as uncertain, is a result to note, not a result to build a shelf around.

Put the four together and the honest reading is this: the trials are too small and too different in dose, duration and population to settle the question, three of the four pooled analyses could not find a reliable effect, and the one that did found a modest one it does not trust. That is a long way from what the supplement aisle implies.

Sources for this section: [3] Effectiveness of oral vitamin D supplementation in lessening disease severity among patients with psoriasis: A systematic review and meta-analysis of randomized controlled trials · [6] Psoriasis and Vitamin D: A Systematic Review and Meta-Analysis · [7] Efficacy and safety of vitamin D supplementation on psoriasis: A systematic review and meta-analysis · [8] Effectiveness and safety of dietary supplements in the adjunctive treatment of psoriasis: a systematic review and network meta-analysis

What the professional guidance actually recommends

The National Psoriasis Foundation's medical board, reviewing 55 studies, made one vitamin D recommendation and it is narrower than people expect: a weak recommendation for supplementation in people with psoriatic arthritis, alongside weight reduction, and always in conjunction with standard medical therapy ^[2]. For psoriasis of the skin without arthritis, no recommendation. The current clinical-practice review of nutrition in psoriasis, written for the clinicians who field this question, spends its recommendations on the Mediterranean diet, calorie restriction and the conditional case for gluten-free eating, and vitamin D supplementation is not among them ^[5].

There is a reason people believe otherwise, and it is the same survey that drives most psoriasis food beliefs. When the National Psoriasis Foundation asked its members what had helped, 41% of those who had added oral vitamin D reported skin improvement ^[4]. That is a report of belief from people who chose the supplement and then judged their own skin, with no comparison group. It is worth knowing. It is not what a trial is for.

Sources for this section: [2] Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic Review · [4] Dietary Behaviors in Psoriasis: Patient-Reported Outcomes from a U.S. National Survey · [5] Nutrition and Psoriasis: The Latest Evidence and How to Approach Nutrition in Clinical Practice

Two decisions that belong in separate boxes

None of this means vitamin D does not matter to you. It means the skin is not the reason to decide about it. Whether your level should be measured, and what to do if it is low, are questions for your doctor that have nothing to do with plaques, and the answer to them does not change with anything on this page.

Keep the two decisions in separate boxes. A blood test and whatever follows it is a question about vitamin D. Expecting that to clear plaques is a treatment claim that three of the four pooled analyses could not support and the fourth supports with low-to-moderate certainty. The professional recommendation that does exist, weak and for psoriatic arthritis, comes with the condition that dietary interventions are used in conjunction with standard medical therapy, never instead of it ^[2].

Where vitamin D leaves the plate

Vitamin D is a poor food question: the research cited here is about blood levels and tablets, not about what is on the plate. So if what you wanted from this page was a food answer for psoriasis, the answer is on a different page, and it is better evidenced than anything here.

The eating pattern with a randomised trial showing psoriasis plaques improving is the Mediterranean diet, which in a 16-week trial produced a between-group improvement of -3.4 on the severity index, with nine of 19 people in the diet arm reaching a 75% reduction against none of the controls ^[1]. Its protocol asked for fish or seafood three or more times a week, including oily fish ^[9], for reasons that have nothing to do with a supplement. The free seven-day psoriasis week on this site is that pattern, cooked, with salmon on the menu for the same reasons.

Sources for this section: [1] Mediterranean Diet and Patients With Psoriasis: The MEDIPSO Randomized Clinical Trial